Analysis: McKesson Corporation

US:MCK

Why is McKesson Corporation stock rising?

  • Fiscal 2027 adjusted EPS guidance raised to $44.20-$45.00 from $43.80-$44.60.
  • New Moore, Oklahoma regional distribution center expected to increase throughput by 75% versus the prior facility.
  • SCRI and Pfizer collaboration expected to deploy a next-generation clinical trial delivery model to streamline oncology trial operations.

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for McKesson Corporation and 4,900+ companies.

Sign in
5-day free pass. No card required.